Skip to main content

Advertisement

SpringerLink
Log in

Is There a Link Between Angiotensin Receptor Blockers and Cancer?

  • Clinical Trial Report
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Deshayes F, Nahmias C: Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005, 16:293–299.

    Article  CAS  PubMed  Google Scholar 

  2. Pfeffer MA, Swedberg K, Granger CB, et al.: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003, 362:759–766.

    Article  CAS  PubMed  Google Scholar 

  3. • Strauss MH, Hall AS: Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation 2006, 114:838–854. Excellent review about the ARB-MI paradoxon.

  4. Levy BI: How to explain the differences between renin angiotensin system modulators. Am J Hypertens 2005, 18(9 Pt 2):134S–141S.

    Article  CAS  PubMed  Google Scholar 

  5. • Levy BI: Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation 2004, 109:8–13. Excellent review about the underlining mechanisms that may lead to delirious effects of angiotension receptors antagonism.

  6. Reudelhuber TL: The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous. Hypertension 2005, 46:1261–1262.

    Article  CAS  PubMed  Google Scholar 

  7. D’Amore A, Black MJ, Thomas WG: The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 2005, 46:1347–1354.

    Article  PubMed  Google Scholar 

  8. Senbonmatsu T, Ichihara S, Price E Jr, et al.: Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000, 106:R25–R29.

    Article  CAS  PubMed  Google Scholar 

  9. • Messerli FH, Bangalore S, Ruschitzka F: Angiotensin receptor blockers: baseline therapy in hypertension? Eur Heart J 2009, 30:2427–2430. Metaanalysis questioning the use of ARBS as baseline therapy in hypertension.

  10. FDA Drug Safety Communication: Ongoing safety review of Benicar and cardiovascular events. US Food and Drug Administration, June 11, 2010. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm215222.htm. Accessed September 21, 2010.

  11. Walther T, Menrad A, Orzechowski HD, et al.: Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 2003, 17:2061–2067.

    Article  CAS  PubMed  Google Scholar 

  12. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA: Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009, 8:1676–1683.

    Article  CAS  PubMed  Google Scholar 

  13. Nissen SE: Angiotensin-receptor blockers and cancer: urgent regulatory review needed. Lancet Oncol 2010, 11:605–606.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Conflicts of Interest: F. Enseleit: none; F. Ruschitzka: Speaker honoraria from Merck Sharp & Dohme, Novartis, Pfizer, Servier.

Author information

Authors and Affiliations

  1. Cardiovascular Center Cardiology, University Hospital, Rämistrasse 100, 8091, Zürich, Switzerland

    Frank Enseleit & Frank Ruschitzka

Authors
  1. Frank Enseleit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Ruschitzka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Ruschitzka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enseleit, F., Ruschitzka, F. Is There a Link Between Angiotensin Receptor Blockers and Cancer?. Curr Hypertens Rep 13, 5–7 (2011). https://doi.org/10.1007/s11906-010-0162-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0162-y

Keywords

Search

Navigation